Philip Leung
Партнер,
Philip
Специализация
Phil Leung is the leader of our Asia-Pacific Mergers & Acquisitions practice and heads up the firm's Greater China Healthcare & Life Sciences practice. He is also an active contributor to Bain's Consumer Products, Retail and Financial Services practices.
Phil is a trusted advisor to a wide range of multinational and local companies. Since joining Bain in 1996, he has worked extensively on growth strategy, transformation programs, M&A and joint ventures in Greater China and throughout Asia-Pacific. In addition to his work with clients, Phil has also led the internal development of Bain's perspectives on mergers and acquisitions, including a global study on joint ventures.
Phil has authored many articles published in international and local media outlets and his views on the M&A landscape in Asia have been widely quoted.
Phil earned his MBA from Harvard University and graduated with an undergraduate degree in business administration, with highest honors, from University of California at Berkeley.
Recent Insights
- “How M&A and Divestitures Helped Asia’s Conglomerates,” M&A Report, 16.02.2021 , Report
- “Learning from Japan’s Disappointing M&A Boom,” Brief, 15.04.2020
- “Philip Leung: China Outbound M&A ,” Video, 19.12.2018
- “More Rigor Means Better Results in China’s Global Pursuit,” Brief, 10.10.2018
- “The Secrets to Successful Joint Ventures,” Forbes.com, 11.04.2017 , Article
In the News
- “Foreign asset managers are eyeing China’s vast pool of savings,” The Economist, 10.06.2021 , Прямые инвестиции
- “Foreign asset managers are eyeing China’s vast pool of savings,” The Economist, 08.06.2021 , Прямые инвестиции
- “Chinese firms may face more competition for overseas deals,” South China Morning Post, 11.10.2018
- “China FDA's Sovaldi nod could usher in more fast track approvals,” S&P Global, 29.09.2017 , Фармацевтика
- “Seven steps that can spell cross-border M&A success for Chinese companies,” South China Morning Post, 28.10.2016